Focusing on the equity investment in early and growing stage enterprises with highly innovative products which have independent intellectual property rights, in the field of medical devices, health food, CRO or health services, TigerYeah is working together with the invested enterprises for the development of healthcare industry to create value and make contributions to the public health for China and even for the global.
TigerYeah investment management team's core members, graduated from the top domestic medical institutions, has experienced the change from clinician to the management team member of pharmaceutical companies and the upgrading from the medical theory to the industrial practice. In the assessment of the projects, we make investment decisions via comprehensive and prospective research and analysis, evaluating not only from the scientific point of view and market size, but also considering the industrial trends, whether the product fits the market needs or represents the trend of the industry future.
By utilizing industry-wide experience and resources, TigerYeah can provide enterprises with all round post-investment services and counseling to accelerate the product into market. By leveraging Tigermed's platform, we are able to help the invested enterprises to connect with upstream and downstream enterprises, to expand the resources, so as to create greater value for invested portfolio companies and achieve greater return for investors.